gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · IARTHealthcareSurgical Instruments

Integra LifeSciences Holdings (IART)

$14.82+8.73%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$14.82▲ 31.15% in range
Nov 4, 2025Low $8.90 · High $19.85Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Integra LifeSciences closed at $14.82 on Nov 4, up 8.73%, 25.3% below its 52-week closing high. Volume of 1.2M shares was 0.93× its 20-day average (close to normal).

Split-adjusted performance: +11.3% over one month, +5.9% over six months, +29.0% over one year.

In the quarter ended Sep 30, 2026, revenue was $411.18M, up 2.3% from a year earlier, with a net margin of 3.6%.

Short interest was 7.3M shares at the Oct 15 settlement (11.0% of float, 5.5 days to cover).

Market cap$1.15B77.8M shares
Revenue · quarter$411.2M+2.3% YoY
Diluted EPS$0.19—
P/E · TTM88.6×P/S 0.7×
Net margin3.6%Gross 51.0%
Dividend yieldNone
52-week range8.90 – 19.85−25.3% from high
Volume1.2M0.93× 20-day avg
Volatility · 60d69.7%Annualised
Short % of float11.0%5.5 days to cover
Net cash-$1.51BCash $311.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +21.1%1M +11.3%3M −13.3%6M +5.9%YTD +19.3%1Y +29.0%3Y −57.7%5Y −78.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum58
Revenue growth31
Net margin67
Value (low P/E)10
Size71

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short7.3M+0.7% vs prior
Days to cover5.5Settled Oct 15
% of float11.0%
Short vol. 10d57.7%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
IARTIntegra LifeSciences$14.82+8.73%+5.9%+2.3%3.6%88.6$1.15B
SGPSpyGlass Pharma$34.450.00%+37.5%———$1.15BCompare
IRMDiRadimed$88.58+9.21%+2.7%+14.2%26.9%47.2$1.13BCompare
SIBNSI-BONE$24.95+4.96%+92.1%+15.2%−7.3%—$1.12BCompare
PRCTPROCEPT BioRobotics$21.66+7.39%−12.7%+19.3%−28.4%—$1.24BCompare
ATECAlphatec Holdings$8.28+10.84%+18.5%+12.6%−2.5%—$1.27BCompare
AORTArtivion$26.45+11.56%−23.8%+11.3%−10.7%—$1.29BCompare
TNDMTandem Diabetes Care$19.05+7.93%+5.7%+5.8%−8.3%—$1.33BCompare
BBNXBeta Bionics$16.95+12.25%+60.4%+30.3%−68.6%—$921.5MCompare

News about Integra LifeSciences

All news →
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IARTGlobeNewswire Inc. · Oct 27, 2026▼ NegativeIntegra: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Oct 21, 2026NeutralIntegra LifeSciences (IART) Surpasses Q3 Earnings EstimatesZacks Investment Research · Oct 21, 2026NeutralIntegra LifeSciences Reports Third Quarter 2026 Financial ResultsGlobeNewswire Inc. · Oct 21, 2026NeutralIART vs. PEN: Which Stock Is the Better Value Option?Zacks Investment Research · Oct 1, 2026▲ Positive

Quick answers

What does Integra LifeSciences do?
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies.
What is IART's market cap?
$1.15B, based on the Nov 4 close of $14.82.
What is IART's P/E ratio?
88.6× trailing-twelve-month earnings of $13.01M.
Does Integra LifeSciences pay a dividend?
No regular cash dividend has been paid in the last year.
How much of IART is sold short?
7.3M shares, 11.0% of float, as of Oct 15, 2026.
What sector is IART in?
Healthcare, in the Surgical Instruments industry.

About Integra LifeSciences

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

HQ: Princeton, NJ4,427 employeesListed Aug 16, 1995integralife.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology